Found 311 results[ Author] Title Type Year
Filters: First Letter Of Last Name is S [Clear All Filters]
Time Sensitive Parameters of Immune Reconstitution Measured Between Day 100 and 1 Year Predict Survival After Unrelated Cord Blood Transplant (UCBT): The Dynamic Impact of Dendritic Cells, Tregs, and Thymic Recovery. In (Vol. 17 No 2 Su, p. S229). presented at the 2011, Honolulu, HI: Elsevier. Retrieved from http://www.bbmt.org/article/S1083-8791%2810%2900803-7/fulltext. (2011).
Clinical trials referral resource. Current clinical trials of fenretinide. Oncology (Williston Park), 15(12), 1595-6, 1598, 1600. presented at the 2001 Dec.. (2001).
Novel Microbial-Based Immunotherapy Approach for Crohn's Disease. Front Med (Lausanne), 6, 170. presented at the 2019. doi:10.3389/fmed.2019.00170. (2019).
A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Multivitamin Supplementation for Age-Related Lens Opacities. Clinical Trial of Nutritional Supplements and Age-Related Cataract Report No. 3. Ophthalmology, 115, 599-607 e1. presented at the 04/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18387406. (2008).
Outcomes after liver transplantation in young infants. J Pediatr Gastroenterol Nutr, 47(4), 486-92. presented at the 2008 Oct. doi:10.1097/MPG.0b013e318175d7d2. (2008).
Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial. Circ Res, 114(8), 1292-301. presented at the 2014 Apr 11. doi:10.1161/CIRCRESAHA.114.302854. (2014).
Does Transendocardial Injection of Mesenchymal Stem Cells Improve Myocardial Function Locally or Globally?: An Analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) Randomized Trial. Circ Res, 114, 1292-1301. presented at the 04/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24449819. (2014).
MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology, 138(1), 159-64. presented at the 2010 Jan. doi:10.1053/j.gastro.2009.09.053. (2010).
MELD (The Model for End-Stage Liver Disease (MELD)) Score Is an Important Predictor of Pretransplantation Mortality in HIV-Infected Liver Transplant Candidates. Gastroenterology, 138, 159-164. presented at the 01/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19800334. (2010).
The Development of a Clinical Decision Support for Illicit Substance Use in Primary Care. In 8th Annual International Network on Brief Interventions for Alcohol Problems (INEBRIA). presented at the 09/21-23/2011, Boston, MA. Retrieved from http://www.bumc.bu.edu/care/education-and-training-programs/inebria/. (2011).
Developments in clinical cell therapy. Cytotherapy, 12(3), 425-8. presented at the 2010 May. doi:10.3109/14653240903511952. (2010).
Effectiveness of a Resin-Modified Glass Ionomer Liner in Reducing Hypersensitivity in Posterior Restorations: A Study from the Practitioners Engaged in Applied Research and Learning Network. J Am Dent Assoc, 144, 886-897. presented at the 08/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23904575. (2013).
Effectiveness of a resin-modified glass ionomer liner in reducing hypersensitivity in posterior restorations: a study from the practitioners engaged in applied research and learning network. J Am Dent Assoc, 144(8), 886-97. presented at the 2013 Aug. doi:10.14219/jada.archive.2013.0206. (2013).
Clinical trials referral resource. Current clinical trials of thalidomide. Oncology (Williston Park), 17(3), 369-71, 374-5, 379-80. presented at the 2003 Mar.. (2003).
Cutting edge: novel vaccination modality provides significant protection against mucosal infection by highly pathogenic simian immunodeficiency virus. J Immunol, 190(6), 2495-9. presented at the 2013 Mar 15. doi:10.4049/jimmunol.1202655. (2013).
Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med, 363(21), 2004-14. presented at the 2010 Nov 18. doi:10.1056/NEJMoa1001197. (2010).
Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipients. Am J Transplant, 14(5), 1136-41. presented at the 2014 May. doi:10.1111/ajt.12699. (2014).
Reduction of HIV Persistence Following Transplantation in HIV-Infected Kidney Transplant Recipients. Am J Transplant, 14, 1136-1141. presented at the 05/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24698537. (2014).
Outcomes of Kidney Transplantation in HIV-Infected Recipients. N Engl J Med, 363, 2004-2014. presented at the 11/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed?term=21083386. (2010).
Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin. J Clin Oncol, 15(5), 1897-905. presented at the 1997 May. doi:10.1200/JCO.19188.8.131.527. (1997).
Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials. PLoS ONE, 3, e2043. presented at the 04/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18446196. (2008).
Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials. PLoS One, 3(4), e2043. presented at the 2008 Apr 30. doi:10.1371/journal.pone.0002043. (2008).
Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye.. Invest Ophthalmol Vis Sci, 43(8), 2609-14. presented at the 2002 Aug.. (2002).
Conjunctiva T-Cell subpopulations in Jorgen’s and non-Jorgen’s patients with dry eye. Invest Ophthalmol Vis Sci, 43, 2609-2614. presented at the 2002.. (2002).